Showing results (21-30 of 38) with videos related to

Sort By:
Pageof 4
International Journal of Molecular Sciences|February 13, 2026
Loss of Hepatocyte FOXA3 Improves MASH and Atherosclerosis in Hyperlipidemic Ldlr-Deficient MiceHui Wang, Shuwei Hu, Jiayou Wang, et al.
Communications Biology|October 10, 2024
Loss of adipose ATF3 promotes adipose tissue lipolysis and the development of MASHShuwei Hu, Fathima N Cassim Bawa, Yingdong Zhu, et al.
Journal of Lipid Research|August 27, 2025
Loss of hepatic carboxylesterase 3 (CES3) prevents the development of MASLD in miceZaid Batayneh, Xiaoli Pan, Raja Gopoju, et al.
Journal of Lipid Research|March 6, 2024
Hepatic FOXA3 overexpression prevents Western diet-induced obesity and MASH through TGR5Raja Gopoju, Jiayou Wang, Xiaoli Pan, et al.
Journal of Materials Chemistry. B|February 20, 2024
Effect of surface modification on the distribution of magnetic nanorings in hepatocellular carcinoma and immune cellsWangbo Jiao, Nana Wen, Siyao Wang, et al.
Molecular Metabolism|April 30, 2021
Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver diseaseYanyong Xu, Yingdong Zhu, Shuwei Hu, et al.
Obesity (Silver Spring, Md.)|October 24, 2023
Adipocyte retinoic acid receptor α prevents obesity and steatohepatitis by regulating energy expenditure and lipogenesisFathima N Cassim Bawa, Shuwei Hu, Raja Gopoju, et al.
Hepatology (Baltimore, Md.)|October 24, 2020
Hepatocyte Nuclear Factor 4α Prevents the Steatosis-to-NASH Progression by Regulating p53 and Bile Acid Signaling (in mice)Yanyong Xu, Yingdong Zhu, Shuwei Hu, et al.
Pageof 4